As of 2024-12-15, the Relative Valuation of Ascelia Pharma AB (ACE.ST) is (59.38) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 21.40 SEK, the upside of Ascelia Pharma AB based on Relative Valuation is -377.5%.
The range of the Relative Valuation is (58.94) - (57.80) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 31.3x | 31.2x |
| Forward P/E multiples | 31.9x - 34.3x | 33.1x |
| Fair Price | (58.94) - (57.80) | (59.38) |
| Upside | -375.4% - -370.1% | -377.5% |
| Date | P/E |